a smart pen injector compatible with standard cartridges and adaptable to dual chamber cartridges. “Novo Nordisk has strong and established core capabilities within developing, scaling ...

Novo Nordisk has introduced all-in-one ... developing an add-on device for its existing pen range. Smart insulin pens are expected to drive the insulin pen market from $13.8 billion in 2020 ...

Danish drugmaker Novo Nordisk on Wednesday posted another quarter of rapid profit growth, though the story for once wasn’t ...

The Danish pharmaceutical company’s blockbuster Wegovy weight-loss drug just missed sales expectations in the fourth quarter ...

However, Novo Nordisk (NYSE: NVO), a pioneer in the field, remains one of the leaders. That likely won't change anytime soon, since the Denmark-based pharmaceutical giant has an excellent pipeline.

BURLINGAME, CA, UNITED STATES, January 14, 2025 /EINPresswire / -- The Pen Needles Market Report is the result of extensive research and analysis conducted by our team of experienced market ...

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it gave to pharmacy firms, obesity charities and other professional bodies ...

On a frigid day in Copenhagen when Erik Hageman was 2 years old, he tripped over his wooden clogs. His face smashed into the floor. In the emergency room, a surgeon repaired his tongue, which had ...

Finally, some good news for Novo Nordisk (NYSE: NVO) shareholders! Twice in the past two months, the Danish manufacturer of GLP-1 drugs for weight loss and diabetes treatment has reported clinical ...

I’m cautious about Novo Nordisk's stock in the short term due to the recent selloff momentum, which could bottom out if the FDA rejects its petition to restrict compounding alternatives.

Novo Nordisk A/S investors got a much-needed boost from last week’s trial results for an experimental weight-loss shot. But there’s still a long way to go to claw back the declines of the past ...